Patent: 7,455,667
✉ Email this page to a colleague
Summary for Patent: 7,455,667
| Title: | Controlled release device and method using electrothermal ablation |
| Abstract: | Devices and methods are provided for the controlled release or exposure of reservoir contents. The device includes a reservoir cap formed of an electrically conductive material, which prevents the reservoir contents from passing out from the device and prevents exposure of the reservoir contents to molecules outside of the device; an electrical input lead connected to said reservoir cap; and an electrical output lead connected to said reservoir cap, such that upon application of an electrical current through the reservoir cap, via the input lead and output lead, the reservoir cap ruptures to release or expose the reservoir contents. The reservoir contents can comprise a release system containing drug molecules for release or can comprise a secondary device, such as a sensor. In one embodiment, the controlled release system is incorporated into an implantable drug delivery device. |
| Inventor(s): | Uhland; Scott A. (Roslindale, MA), Polito; Benjamin F. (Cambridge, MA), Maloney; John M. (Cambridge, MA), Sheppard, Jr.; Norman F. (Bedford, MA), Herman; Stephen J. (Andover, MA), Yomtov; Barry Y. (Marblehead, MA) |
| Assignee: | MicroCHIPS, Inc. (Bedford, MA) |
| Application Number: | 11/259,301 |
| Patent Claims: | see list of patent claims |
Details for Patent 7,455,667
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Nps Pharmaceuticals, Inc. | NATPARA | parathyroid hormone | For Injection | 125511 | 01/23/2015 | ⤷ Try a Trial | 2022-08-16 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
